ERBA Diagnostics (ERBA) Stock Price, News & Analysis

Company Overview

ERBA Diagnostics (OTCMKTS:ERBA) is a global provider of in vitro diagnostic solutions, offering a comprehensive portfolio of clinical laboratory instruments, reagents and software. The company’s product suite is designed to support clinical chemistry, immunodiagnostics, haematology and molecular diagnostics testing, enabling healthcare providers to deliver accurate and timely results for patient diagnosis and monitoring.

The company’s core offerings include fully automated chemistry analyzers, ELISA and chemiluminescence immunoassay systems, haematology analyzers and molecular testing platforms. ERBA Diagnostics also supplies a broad range of reagents and quality control materials, as well as laboratory information management systems (LIMS) that streamline workflow and data integration in diagnostic laboratories.

ERBA Diagnostics serves a network of distributors and end users across multiple regions, with a presence in Asia, Eastern Europe, Latin America, the Middle East and Africa. By leveraging its global footprint, the company delivers localized sales, technical support and training services to hospitals, reference laboratories and independent testing facilities.

Part of the ErbaMannheim Group, ERBA Diagnostics combines over three decades of industry experience with ongoing investment in research and development. The company places a strong emphasis on regulatory compliance and quality assurance, maintaining certifications and adhering to international standards to support the needs of clinical laboratories worldwide.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.01 to $0.31
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ERBA Stock Analysis - Frequently Asked Questions

How have ERBA shares performed this year?

ERBA Diagnostics' stock was trading at $0.0350 at the beginning of the year. Since then, ERBA stock has increased by 0.0% and is now trading at $0.0350.

How do I buy shares of ERBA Diagnostics?

Shares of ERBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ERBA Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ERBA Diagnostics investors own include EKF Diagnostics (EKF), Cannabis Wheaton Income (CBWTF), ContraFect (CFRX), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), iQIYI (IQ) and Myriad Genetics (MYGN).

Company Calendar

• Today: 9/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ERBA
• Previous Symbol: NYSEMKT:ERB
• CIK: 1095858
• Web: www.erbadiagnostics.com
• Phone: 305-324-2300
• Fax: 305-324-2395
• Employees: 134
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A